Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Microtubule-associated protein 7 domain-containing protein 1 (MAP7D1) is a structural protein primarily involved in the stabilization and organization of microtubule cytoskeletons within cells[1][3][5]. It localizes to the centrosome and spindle, facilitating microtubule stability and influencing cellular processes such as motility and neurite outgrowth[1][3][5]. MAP7D1 is also important for the maintenance of acetylated microtubules, which are associated with stable cellular structures[1]. It is predominantly expressed in the brain, muscle, and reproductive tissues[2][6]. While not a direct therapeutic target or receptor, genetic disruption of MAP7D1 increases susceptibility to doxorubicin-induced cardiomyopathy and heart failure, making it a potential biomarker for predicting adverse effects in cancer therapy involving anthracyclines[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microtubule-associated protein 7 domain-containing protein 1 (MAP7D1).